UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 381

Sortiert nach

Effects of a Low-Molecular-Weight Heparin on Thrombus Regression and Recurrent Thromboembolism in Patients with Deep-Vein Thrombosis

The New England journal of medicine, 2001-03, Vol.344 (9), p.626-631

2001

Volltextzugriff (PDF)

Low-molecular-weight heparin in the acute and long-term treatment of deep vein thrombosis

Thrombosis and haemostasis, 2003-04, Vol.89 (4), p.674

2003

Volltextzugriff (PDF)

Cellular effects of heparin on the production and release of tissue factor pathway inhibitor in human endothelial cells in culture

Arteriosclerosis, thrombosis, and vascular biology, 1999-09, Vol.19 (9), p.2251

1999

Volltextzugriff (PDF)

Expression, localization, and activity of tissue factor pathway inhibitor in normal and atherosclerotic human vessels

Arteriosclerosis, thrombosis, and vascular biology, 2000-05, Vol.20 (5), p.1362

2000

Volltextzugriff (PDF)

Plasminogen activator expression in human atherosclerotic lesions

Arteriosclerosis, thrombosis, and vascular biology, 1995-09, Vol.15 (9), p.1444

1995

Volltextzugriff (PDF)

Platelet factor 4 neutralizes heparan sulfate-enhanced antithrombin inactivation of factor Xa by preventing interaction(s) of enzyme with polysaccharide

Biochemical and biophysical research communications, 2003-11, Vol.311 (1), p.71-76

2003

Volltextzugriff (PDF)

Cost effectiveness of bemiparin sodium versus unfractionated heparin and oral anticoagulants in the acute and long-term treatment of deep vein thrombosis

PharmacoEconomics, 2006, Vol.24 (1), p.81-92

2006

Volltextzugriff (PDF)

Low‐dose heparin to low molecular weight heparin prophylaxis: in pursuit of excellence – a personal perspective

Journal of thrombosis and haemostasis, 2005-02, Vol.3 (2), p.195-209

Kakkar, V. V.

2005

Volltextzugriff (PDF)

Blood coagulation in patients with chronic heart failure: Evidence for hypercoagulable state and potential for pharmacological intervention

Drugs (New York, N.Y.), 2003-01, Vol.63 (6), p.565-576

2003

Volltextzugriff (PDF)

Low‐Molecular‐Weight Heparin versus Warfarin for Prevention of Recurrent Venous Thromboembolism: A Randomized Trial

World journal of surgery, 1996-06, Vol.20 (5), p.521-527

1996

Volltextzugriff (PDF)

Thrombin induces the redistribution and acute release of tissue factor pathway inhibitor from specific granules within human endothelial cells in culture

Arteriosclerosis, thrombosis, and vascular biology, 1995-11, Vol.15 (11), p.2055

1995

Volltextzugriff (PDF)

Tissue factor pathway inhibitor in endothelial cells colocalizes with glycolipid microdomains/caveolae. Regulatory mechanism(s) of the anticoagulant properties of the endothelium

Arteriosclerosis, thrombosis, and vascular biology, 1997-11, Vol.17 (11), p.2964

1997

Volltextzugriff (PDF)

Randomized trial of different regimens of heparins and in vivo thrombin generation in acute deep vein thrombosis

Blood, 2002-03, Vol.99 (6), p.1965-1970

2002

Volltextzugriff (PDF)

Plasminogen activation initiated by single-chain urokinase-type plasminogen activator. Potentiation by U937 monocytes

The Journal of biological chemistry, 1989-02, Vol.264 (4), p.2185-2188

1989

Volltextzugriff (PDF)

Use of A direct antithrombin, hirulog, in place of heparin during coronary angioplasty

Circulation (New York, N.Y.), 1993-05, Vol.87 (5), p.1622-1629

1993

Volltextzugriff (PDF)

Fluid flow induces upregulation of synthesis and release of tissue factor pathway inhibitor in vitro

Arteriosclerosis, thrombosis, and vascular biology, 2000-11, Vol.20 (11), p.2474

2000

Volltextzugriff (PDF)

Activation of pro-urokinase by plasmin: Non-michaelian kinetics indicates a mechanism of negative cooperativity

Archives of biochemistry and biophysics, 1989-02, Vol.268 (2), p.438-446

1989

Volltextzugriff (PDF)

Inhibition of human alpha-thrombin by a phosphonate tripeptide proceeds via a metastable pentacoordinated phosphorus intermediate

Journal of molecular biology, 2001-08, Vol.311 (3), p.549-555

2001

Volltextzugriff (PDF)

Effect of unfractionated heparin and long-term treatment with low-molecular-weight heparin, bemiparin, on potassium levels

Thrombosis and haemostasis, 2005-11, Vol.94 (5), p.1109

2005

Volltextzugriff (PDF)

Risk factors and coagulation parameters in relationship to phlebographic response and clinical outcome in the treatment of acute deep vein thrombosis

Thrombosis and haemostasis, 2003-02, Vol.89 (2), p.272

2003

Volltextzugriff (PDF)

Efficacy and Safety of a Low‐Molecular‐Weight Heparin and Standard Unfractionated Heparin for Prophylaxis of Postoperative Venous Thromboembolism: European Multicenter Trial

World journal of surgery, 1997-01, Vol.21 (1), p.2-9

1997

Volltextzugriff (PDF)

Use of low molecular weight heparin in pregnancy

Thrombosis and haemostasis, 1992-12, Vol.68 (6), p.652

1992

Volltextzugriff (PDF)

Lipid peroxides and atherosclerosis

BMJ (Online), 1989-02, Vol.298 (6669), p.281

1989

Volltextzugriff (PDF)

Cold adaptation and the seasonal distribution of acute myocardial infarction

QJM (Oxford. 1994. Print), 1999-12, Vol.92 (12), p.747-751

1999

Volltextzugriff (PDF)

Chronic fatigue syndrome : physical and cardiovascular deconditioning

QJM : An International Journal of Medicine, 1998-07, Vol.91 (7), p.475-481

1998

Volltextzugriff (PDF)

1 – 25 von 381

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(358)
Mit Volltextzugriff
(246)

Publikationsform

Artikel
(381)

Sprache

Englisch
(381)
Japanisch
(31)

Erscheinungsjahr

n.n

Thema

Science & Technology
(373)
Life Sciences & Biomedicine
(361)
Humans
(319)
Hematology
(157)
Biological And Medical Sciences
(129)
Male
(101)
Female
(93)
Medical Sciences
(92)
Biochemistry & Molecular Biology
(90)
Cardiovascular System & Cardiology
(84)
Middle Aged
(83)
Adult
(81)
Peripheral Vascular Disease
(78)
General & Internal Medicine
(61)
Medicine, General & Internal
(61)
Aged
(53)
Molecular Sequence Data
(53)
Animals
(43)
Fundamental And Applied Biological Sciences. Psychology
(38)
Thrombophlebitis - Prevention & Control
(36)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Effects of a Low-Molecular-Weight Heparin on Thrombus Regression and Recurrent Thromboembolism in Patients with Deep-Vein Thrombosis

Low-molecular-weight heparin in the acute and long-term treatment of deep vein thrombosis

Cellular effects of heparin on the production and release of tissue factor pathway inhibitor in human endothelial cells in culture

Expression, localization, and activity of tissue factor pathway inhibitor in normal and atherosclerotic human vessels

Plasminogen activator expression in human atherosclerotic lesions

Platelet factor 4 neutralizes heparan sulfate-enhanced antithrombin inactivation of factor Xa by preventing interaction(s) of enzyme with polysaccharide

Cost effectiveness of bemiparin sodium versus unfractionated heparin and oral anticoagulants in the acute and long-term treatment of deep vein thrombosis

Low‐dose heparin to low molecular weight heparin prophylaxis: in pursuit of excellence – a personal perspective

Blood coagulation in patients with chronic heart failure: Evidence for hypercoagulable state and potential for pharmacological intervention

Low‐Molecular‐Weight Heparin versus Warfarin for Prevention of Recurrent Venous Thromboembolism: A Randomized Trial

Thrombin induces the redistribution and acute release of tissue factor pathway inhibitor from specific granules within human endothelial cells in culture

Tissue factor pathway inhibitor in endothelial cells colocalizes with glycolipid microdomains/caveolae. Regulatory mechanism(s) of the anticoagulant properties of the endothelium

Randomized trial of different regimens of heparins and in vivo thrombin generation in acute deep vein thrombosis

Plasminogen activation initiated by single-chain urokinase-type plasminogen activator. Potentiation by U937 monocytes

Use of A direct antithrombin, hirulog, in place of heparin during coronary angioplasty

Fluid flow induces upregulation of synthesis and release of tissue factor pathway inhibitor in vitro

Activation of pro-urokinase by plasmin: Non-michaelian kinetics indicates a mechanism of negative cooperativity

Inhibition of human alpha-thrombin by a phosphonate tripeptide proceeds via a metastable pentacoordinated phosphorus intermediate

Effect of unfractionated heparin and long-term treatment with low-molecular-weight heparin, bemiparin, on potassium levels

Risk factors and coagulation parameters in relationship to phlebographic response and clinical outcome in the treatment of acute deep vein thrombosis

Efficacy and Safety of a Low‐Molecular‐Weight Heparin and Standard Unfractionated Heparin for Prophylaxis of Postoperative Venous Thromboembolism: European Multicenter Trial

Use of low molecular weight heparin in pregnancy

Lipid peroxides and atherosclerosis

Cold adaptation and the seasonal distribution of acute myocardial infarction

Chronic fatigue syndrome : physical and cardiovascular deconditioning

Suchergebnisse filtern